Increased Expression of the Mineralocorticoid Receptor in the Brain of Spontaneously Hypertensive Rats

Journal of Neuroendocrinology

Volumn 24, Issue 9, 2012, Pages 1249-1258

  Pietranera, L ^a,b   Brocca, M E ^a   Cymeryng, C ^b   Gomez Sanchez, E ^c   Gomez Sanchez, C E ^c   Roig, P ^a   Lima, A ^a   De Nicola, A F ^a,b  

^a CONICET ^*  (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Aldosterone; Cortisol corticosterone; Glucocorticoids; Membrane nuclear; Mineralocorticoids; Neuroactive steroids; Receptors; Steroids

Indexed keywords

GLUCOCORTICOID RECEPTOR; MESSENGER RNA; MINERALOCORTICOID RECEPTOR; OXPRENOATE POTASSIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BRAIN DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; GENE EXPRESSION; GENETIC ASSOCIATION; HIPPOCAMPAL CA3 REGION; HIPPOCAMPUS; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAGNOCELLULAR NUCLEUS; MALE; NEUROPATHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STAINING; UPREGULATION; WISTAR KYOTO RAT;

ANIMALS; BLOOD PRESSURE; HIPPOCAMPUS; HYPOTHALAMUS; MINERALOCORTICOID RECEPTOR ANTAGONISTS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, GLUCOCORTICOID; RECEPTORS, MINERALOCORTICOID; SPIRONOLACTONE;

EID: 84865314925     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2012.02332.x     Document Type: Article

References (82)

1. Mulrow PJ, Forman BH. The tissue effects of mineralocorticoids. Am J Med 1972; 53: 561-572.
2. Krozowski Z, Wendell K, Ahima R, Harlan R. Type I corticosteroid receptor-like immunoreactivity in the rat salivary glands and distal colon: modulation by corticosteroids. Mol Cell Endocrinol 1992; 85: 21-32.
3. Yang J, Fuller PJ. Interactions of the mineralocorticoid receptor - within and without. Mol Cell Endocrinol 2012; 350: 196-205.
4. Ratka A, Sutanto W, Bloemers M, De Kloet ER. On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation. Neuroendocrinology 1989; 50: 117-123.
5. Joels M, De Kloet ER. Mineralocorticoid and glucocorticoid receptors in the brain. Implications for ion permeability and transmitter systems. Prog Neurobiol 1994; 43: 1-36.
6. Gomez-Sanchez EP. Mineralocorticoid receptors in the brain and cardiovascular regulation: minority rule? Trends Endocrinol Metab 2011; 22: 179-187.
7. Van den Berg DT, De Jong W, De Kloet ER. Mineralocorticoid antagonist inhibits stress-induced blood pressure response after repeated daily warming. Am J Physiol 1994; 267: E921-E926.
8. De Kloet ER, Meijer OC, Vreugdenhil E, Joels M. The yin and yang of nuclear receptors: symposium on nuclear receptors in brain, Oegstgeest, The Netherlands, 13-14 April 2000. Trends Endocrinol Metab 2000; 11: 245-248.
9. Dorrance AM, Rupp NC, Nogueira EF. Mineralocorticoid receptor activation causes cerebral vessel remodeling and exacerbates the damage caused by cerebral ischemia. Hypertension 2006; 47: 590-595.
10. Pietranera L, Saravia F, Roig P, Lima A, De Nicola AF. Mineralocorticoid treatment upregulates the hypothalamic vasopressinergic system of spontaneously hypertensive rats. Neuroendocrinology 2004; 80: 100-110.
11. Pietranera L, Saravia F, Gonzalez Deniselle MC, Roig P, Lima A, De Nicola AF. Abnormalities of the hippocampus are similar in deoxycorticosterone acetate-salt hypertensive rats and spontaneously hypertensive rats. J Neuroendocrinol 2006; 18: 466-474.
12. Gomez-Sanchez EP, Gomez-Sanchez CE. Central regulation of blood pressure by the mineralocorticoid receptor Mol Cell Endocrinol 2012; 350: 289-298.
13. Rigsby CS, Ergul A, Portik DV, Pollock DM, Dorrance AM. Effects of spironolactone on cerebral vessel structure in rats with sustained hypertension. Am J Hypertens 2011; 24: 708-715.
14. Xue B, Beltz TG, Yu Y, Guo F, Gomez-Sanchez CE, Hay M, Johnson AK. Central interactions of aldosterone and angiotensin II in aldosterone- and angiotensin II-induced hypertension. Am J Physiol Heart Circ Physiol 2011; 300: H555-H564.
15. Macleod MR, Johansson IM, Soderstrom I, Lai M, Gido G, Wieloch T, Seckl JR, Olsson T. Mineralocorticoid receptor expression and increased survival following neuronal injury. Eur J Neurosci 2003; 17: 1549-1555.
16. Lai M, Horsburgh K, Bae SE, Carter RN, Stenvers DJ, Fowler JH, Yau JL, Gomez-Sanchez CE, Holmes MC, Kenyon CJ, Seckl JR, Macleod MR. Forebrain mineralocorticoid receptor overexpression enhances memory, reduces anxiety and attenuates neuronal loss in cerebral ischaemia. Eur J Neurosci. 2007; 25:1832-1842.
17. Munier M, Law F, Meduri G, Le Menuet D, Lombès M. Mineralocorticoid receptor overexpression facilitates differentiation and promotes survival of embryonic stem cell-derived neurons. Endocrinology 2012; 153: 1330-1340.
18. Reul JM, De Kloet ER. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 1985; 117: 2505-2511.
19. Groeneweg FL, Karst H, De Kloet ER, Joels M. Rapid non-genomic effects of corticosteroids and their role in the central stress response. J Endocrinol 2011; 209: 153-167.
20. Edwards CR, Stewart PM, Burt D, Brett L, McIntyre MA, Sutanto WS, De Kloet ER, Monder C. Localisation of 11 beta-hydroxysteroid dehydrogenase--tissue specific protector of the mineralocorticoid receptor. Lancet 1988; 2: 986-989.
21. Seckl JR. 11beta-Hydroxysteroid dehydrogenase in the brain: a novel regulator of glucocorticoid action? Front Neuroendocrinol 1997; 18: 49-99.
22. Yongue BG, Roy EJ. Endogenous aldosterone and corticosterone in brain cell nuclei of adrenal-intact rats: regional distribution and effects of physiological variations in serum steroids. Brain Res 1987; 436: 49-61.
23. McEwen BS, Lambdin TC, Rainbow TC, De Nicola AF. Aldosterone effects on salt appetite in adrenalectomized rats. Neuroendocrinology 1986; 43: 38-43.
24. Ahima R, Krosowski Z, Harlan R. Type I corticosteroid receptor-like immunoreactivity in the rat CNS: distribution and regulation by corticosteroids. J Comp Neurol 1991; 313: 522-538.
25. Pietranera L, Saravia FE, McEwen BS, Lucas LL, Johnson AK, De Nicola AF. Changes in Fos expression in various brain regions during deoxycorticosterone acetate treatment: relation to salt appetite, vasopressin mRNA and the mineralocorticoid receptor. Neuroendocrinology 2001; 74: 396-406.
26. Gutkind JS, Kurihara M, Saavedra JM. Increased angiotensin II receptors in brain nuclei of DOCA-salt hypertensive rats. Am J Physiol 1988; 255: H646-H650.
27. Van Tol HH, Van den Buuse M, deJong W, Burbach JP. Vasopressin and oxytocin gene expression in the supraoptic and paraventricular nucleus of the spontaneously hypertensive rat (SHR) during development of hypertension. Brain Res 1988; 464: 303-311.
28. Burrell LM, Philips PA, Risvanis J, Aldred KL, Hutchins AM, Johnston CI. Attenuation of genetic hypertension after short-term vasopressin V1A receptor antagonism. Hypertension 1995; 26: 828-834.
29. Martinez F, Mansego ML, Escudero JC, Redon J, Chaves FJ. Association of a mineralocorticoid receptor gene polymorphism with hypertension in a Spanish population. Am J Hypertens 2009; 22: 649-655.
30. Rahmouni K, Sibug RM, De Kloet ER, Barthelmebs M, Grima M, Imbs JL, De Jong W. Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension. Eur J Pharmacol 2002; 436: 207-216.
31. Hashimoto K, Makino S, Hirasawa R, Takao T, Sugawara M, Murakami K, Ono K, Ota Z. Abnormalities in the hypothalamic-pituitary-adrenal axis in spontaneously hypertensive rats during development of hypertension. Endocrinology 1989; 125: 1161-1167.
32. Gomez F, Lahmame A, De Kloet ER, Armario A. Hypothalamic-pituitary adrenal response to chronic stress in five inbred rat strains: differential responses are mainly located at the adrenocortical level. Neuroendocrinology 1996; 63: 327-337.
33. Rahmouni K, Barthelmebs M, Grima M, Imbs JL, deJong W. Involvement of brain mineralocorticoid receptor in salt-enhanced hypertension in spontaneously hypertensive rats. Hypertension 2001; 38: 902-906.
34. Kenyon CJ, De Conti GA, Cupolo NA, Morris DJ The role of aldosterone in the development of hypertension in spontaneously hypertensive rats. Endocrinology 1981; 109: 1841-1845.
35. Koch B, Sakly M, Lutz-Bucher B. Specific mineralocorticoid receptors in the hippocampus of spontaneously hypertensive (SH) rats. I. Evidence for a sex difference. Horm Metab Res 1982; 14: 166.
36. Konishi A, Tazawa C, Miki Y, Darnel AD, Suzuki T, Ohta Y, Tabayashi K, Sasano H. The possible roles of mineralocorticoid receptor and 11b-hydroxysteroid dehydrogenase type 2 in cardiac fibrosis in the spontaneously hypertensive rat. J Steroid Biochem Mol Biol 2003; 85: 439-442.
37. Mirshahi M, Nicolas C, Agarwal MK. Enhanced activation of the mineralocorticoid receptor in genetically hypertensive rats. Biochem Biophys Res Commun 1998; 244: 120-125.
38. Sutanto W, Oitzl MS, Rots NY, Schobitz B, Van den Berg DTWM, Van Dijken HH, Mos J, Cools AR, Tilders FJH, Koolhaas JM. Corticosteroid receptor plasticity in the central nervous system of various rat models. Endocr Regul 1992; 26: 111-118.
39. Sabbatini M, Catalani A, Consoli C, Marletta N, Tomassoni D, Avola R. The hippocampus in spontaneously hypertensive rats: an animal model of vascular dementia? Mech Ageing Dev 2002; 123: 547-559.
40. Tomassoni D, Avola R, Di Tullio MA, Sabbatini M, Vitaioli L, Amenta F. Increased expression of glial fibrillary acidic protein in the brain of spontaneously hypertensive rats. Clin Exp Hypertens 2004; 26: 335-350.
41. Amenta F, Tayebati SK, Tomassoni D. Spontaneously hypertensive rat neuroanatomy: applications to pharmacological research. Ital J Anat Embryol 2010; 115: 13-17.
42. Pietranera L, Saravia FE, Roig P, Lima A, De Nicola AF. Protective effects of estradiol in the brain of rats with genetic or mineralocorticoid-induced hypertension. Psychoneuroendocrinology 2008; 33: 270-281.
43. Ueno M, Sakamoto H, Tomimoto H, Akiguchi I, Onodera M, Huang CL, Kanenishi K. Blood-brain barrier is impaired in the hippocampus of young adult spontaneously hypertensive rats. Acta Neuropathol (Berl) 2004; 107: 532-538.
44. Pietranera L, Lima A, Roig P, De Nicola AF. Involvement of brain-derived neurotrophic factor and neurogenesis in oestradiol neuroprotection of the hippocampus of hypertensive rats. J Neuroendocrinol 2010; 22: 1082-1092.
45. Pietranera L, Bellini MJ, Arevalo MA, Goya R, Brocca ME, Garcia-Segura LM, De Nicola AF. Increased aromatase expression in the hippocampus of spontaneously hypertensive rats: effects of estradiol administration. Neuroscience 2011; 174: 151-159.
46. Sabbatini SP, Vitaioli L, Amenta F. The hippocampus in spontaneously hypertensive rats: a quantitative microanatomical study. Neuroscience 2000; 100: 251-258.
47. Cymeryng CB, Dada LA, Podesta EJ. Effect of nitric oxide on rat adrenal zona fasciculata steroidogenesis. J Endocrinol 1998; 158: 197-203.
48. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. San Diego, CA. Academic Press, 1997.
49. Revsin Y, Van Wijk D, Saravia FE, Oitzl MS, De Nicola AF, De Kloet ER. Adrenal hypersensitivity precedes chronic hypercorticism in streptozotocin-induced diabetes mice. Endocrinology 2008; 149: 3531-3539.
50. Jackiewicz E, Szczepanska-Sadowska E, Maslinski W. Expression of mineralocorticoid receptors mRNA in the brain, heart and kidney of Sprague Dawley rats with renovascular hypertension. Brain Res Bull 2005; 65: 23-29.
51. Okugawa G, Omori K, Suzukawa J, Fujiseki Y, Kinoshita T, Inagaki C. Long-term treatment with antidepressants increases glucocorticoid receptor binding and gene expression in cultured rat hippocampal neurones. J Neuroendocrinol 1999; 11: 887-895.
52. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)). Methods 2001; 25: 402-408.
53. Labombarda F, Gonzalez SL, Gonzalez Deniselle MC, Vinson GP, Schumacher M, De Nicola AF, Guennoun R Effects of injury and progesterone treatment on progesterone receptor and progesterone binding protein 25-DX expression in the rat spinal cord. J Neurochem 2003; 87: 902-913.
54. Gomez-Sanchez CE, De Rodriguez AF, Romero DG, Estess J, Warden MP, Gomez-Sanchez MT, Gomez-Sanchez EP. Development of a panel of monoclonal antibodies against the mineralocorticoid receptor. Endocrinology 2006; 147: 1343-1348.
55. Vincent SR, Kimura H. Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience 1992; 46: 755-784.
56. Labombarda F, Gonzalez SL, Gonzalez DM, Guennoun R, Schumacher M, De Nicola AF. Cellular basis for progesterone neuroprotection in the injured spinal cord. J Neurotrauma 2002; 19: 343-355.
57. Ferrini M, Piroli G, Frontera M, Falbo A, Lima A, De Nicola AF. Estrogens normalize the hypothalamic-pituitary-adrenal axis response to stress and increase glucocorticoid receptor immuno-reactivity in hippocampus of aging male rats. Neuroendocrinology 1999; 69: 129-137.
58. Van den Berg DT, De Kloet ER, De Jong W. Central effects of mineralocorticoid antagonist RU-28318 on blood pressure of DOCA-salt hypertensive rats. Am J Physiol 1994; 267: E927-E933.
59. Funder JW. Mineralocorticoid receptor activation and oxidative stress. Hypertension 2007; 50: 840-841.
60. Rigsby CS, Cannady WE, Dorrance AM. Aldosterone: good guy or bad guy in cerebrovascular disease? Trends Endocrinol Metab 2005; 16: 401-406.
61. De Wandener HE. The hypothalamus and hypertension. Physiol Rev 2001; 81: 1599-1658.
62. Imaki T, Naruse M, Harada S, Chikada N, Nakahuma N, Yoshimoto T, Demura H. Stress-induced changes of gene expression in the paraventricular nucleus is enhanced in spontaneously hypertensive rats. J Neuroendocrinol 1998; 10: 633-643.
63. Goncharuk VD, Van Heerikhuize J, Swaab D, Buijs R. Paraventricular nucleus of the human hypothalamus in primary hypertension: activation of corticotrophin-releasing hormone neurons. J Comp Neurol 2002; 443: 321-331.
64. Susic D, Varagic J, Ahn J, Matavelli L, Frohlich ED. Long-term mineralocorticoid receptor blockade reduces fibrosis and improves cardiac performance and coronary hemodynamics in elderly SHR. Am J Physiol Heart Circ Physiol 2007; 292: H175-H179.
65. DeLano FA, Schmid-Schonbein GW. Enhancement of glucocorticoid and mineralocorticoid receptor density in the microcirculation of the spontaneously hypertensive rat. Microcirculation 2004; 11: 69-78.
66. Roman O, Seres J, Pometlova M, Jurcovicova J. Neuroendocrine or behavioral effects of acute or chronic emotional stress in Wistar Kyoto (WKY) and spontaneously hypertensive (SHR) rats. Endocr Regul 2004; 38: 151-155.
67. De Nicola AF, Oliver JT, Birmingham MK. In vitro metabolism of progesterone by the adrenals of spontaneously hypertensive rats. Experientia 1969; 25: 880-881.
68. Komanicky P, Reiss DL, Dale SL, Melby JC. Role of adrenasteroidogenesis inetiology of hypertension in the spontaneously hypertensive rat. Endocrinology; 1982; 111: 219-224.
69. Watanabe M, Nishikawa T, Takagi T, Kamiyama Y, Tamura Y, Kumagai A. Mechanism of suppressed renin-angiotensin system in spontaneously hypertensive rat (SHR). Clin Exp Hypertens 1983; 5: 49-47.
70. Gomez-Sanchez EP, Gomez-Sanchez CE. Is aldosterone synthesized in the CNS regulated and functional? Trends Endocrinol Metab 2003; 14: 444-446.
71. Newfell BG, Iyer LK, Mohammad NN, McGraw AP, Ehsan A, Rosano G, Huang PL, Mendelsohn ME, Jaffe IZ. Aldosterone regulates vascular gene transcription via oxidative stress-dependent and -independent pathways Arterioscler. Thromb Vasc Biol 2011; 31: 1871-1880.
72. Vaziri ND, Ni Z, Oveisi F, Trnavsky-Hobbs DL. Effect of antioxidant therapy on blood pressure and NO synthase expression in hypertensive rats. Hypertension 2000; 36: 957-964.
73. Ren J. Influence of gender on oxidative stress, lipid peroxidation, protein damage and apoptosis in hearts and brains from spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 2007; 34: 432-438.
74. Chan SH, Wu KL, Chang AY, Tai MH, Chan JY. Oxidative impairment of mitochondrial electron transport chain complexes in rostral ventrolateral medulla contributes to neurogenic hypertension. Hypertension 2009; 53: 217-227.
75. Djordjevic J, Vuckovic T, Jasnic N, Cvijic G. Effect of various stressors on the blood ACTH and corticosterone concentration in normotensive Wistar and spontaneously hypertensive Wistar-Kyoto rats. Gen Comp Endocrinol 2007; 153: 217-220.
76. Tornello S, Orti E, De Nicola AF, Rainbow TC, McEwen BS. Regulation of glucocorticoid receptors in brain by corticosterone treatment of adrenalectomized rats. Neuroendocrinology 1982; 35: 411-417.
77. Okret S, Poellinger L, Dong Y, Gustafsson JA. Down-regulation of glucocorticoid receptor mRNA by glucocorticoid hormones and recognition by the receptor of a specific binding sequence within a receptor cDNA clone. Proc Natl Acad Sci USA 1986; 83: 5899-5903.
78. Jaffe IZ, Mendelsohn ME. Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells. Circ Res 2005; 96: 643-650.
79. Krug AW, Allenhofer L, Monticone R, Spinetti G, Gekle M, Wang M, Lakatta EG. Elevated mineralocorticoid receptor activity in aged rat vascular smooth muscle cells promotes a proinflammatory phenotype via extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase and epidermal growth factor receptor-dependent pathways. Hypertension 2010; 55: 1476-1483.
80. Saavedra JM. Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities. Cell Mol Neurobiol 2005; 25: 485-512.
81. Baumann M, Hermans JJ, Janssen BJ, Peutz-Kootstra C, Witzke O, Heemann U, Smits JF, Boudier HA. Transient prehypertensive treatment in spontaneously hypertensive rats: a comparison of spironolactone and losartan regarding long-term blood pressure and target organ damage. J Hypertens 2007; 25: 2504-2511.
82. Geller DS. A mineralocorticoid receptor mutation causing human hypertension. Curr Opin Nephrol Hypertens 2001; 10: 661-665.